NAMS 最新季度財報
公佈日期8/5/2026
實際每股收益(美元)-0.52
實際營收(美元)3.70M
本頁面提供詳細的 NewAmsterdam Pharma Company NV 財報數據,包括最新財報、下一次財報發佈日期、歷史數據,以及 NewAmsterdam Pharma Company NV 財報法說會相關新聞。
| 發布日期 | 報告期末 | 每股收益/預測值 | 營收/預測值 | 每股收益超出預期幅度% | 營收超出預期幅度% |
|---|---|---|---|---|---|
| 8/5/2026 | 06/2026 | -0.52/-0.49 | 3.70M/1.66M | -6.50% | 122.57% |
| 5/7/2026 | 03/2026 | -0.40/-0.49 | 3.04M/858.33K | 19.13% | 254.18% |
| 2/18/2026 | 12/2025 | -0.62/-0.39 | 32.00K/5.12M | -62.16% | -99.37% |
| 11/5/2025 | 09/2025 | -0.61/-0.40 | 348.00K/5.29M | -52.74% | -93.42% |
| 8/6/2025 | 06/2025 | -0.15/-0.49 | 19.14M/1.60M | 70.21% | 1097.93% |
| 5/8/2025 | 03/2025 | -0.34/-0.49 | 2.98M/1.58M | 30.22% | 89.01% |
| 2/26/2025 | 12/2024 | -0.93/-0.49 | 12.77M/1.76M | -90.75% | 627.33% |
| 11/6/2024 | 09/2024 | -0.18/-0.50 | 29.11M/1.87M | 64.82% | 1454.89% |